0001562180-24-001391.txt : 20240216
0001562180-24-001391.hdr.sgml : 20240216
20240216163858
ACCESSION NUMBER: 0001562180-24-001391
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beliveau-Dunn Jeanne
CENTRAL INDEX KEY: 0001714894
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35229
FILM NUMBER: 24649018
MAIL ADDRESS:
STREET 1: C/O XYLEM INC.
STREET 2: 1 INTERNATIONAL DRIVE
CITY: RYE BROOK
STATE: NY
ZIP: 10573
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xylem Inc.
CENTRAL INDEX KEY: 0001524472
STANDARD INDUSTRIAL CLASSIFICATION: PUMPS & PUMPING EQUIPMENT [3561]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 452080495
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 WATER STREET SE
CITY: WASHINGTON
STATE: DC
ZIP: 20003
BUSINESS PHONE: 202-869-9150
MAIL ADDRESS:
STREET 1: 301 WATER STREET SE
CITY: WASHINGTON
STATE: DC
ZIP: 20003
FORMER COMPANY:
FORMER CONFORMED NAME: ITT WCO, Inc.
DATE OF NAME CHANGE: 20110628
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-02-15
false
0001524472
Xylem Inc.
XYL
0001714894
Beliveau-Dunn Jeanne
C/O XYLEM INC.
301 WATER STREET SE
WASHINGTON
DC
20003
true
false
false
false
false
Common Stock
2024-02-15
4
S
false
1835.00
124.5075
D
7298.00
D
This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,835 Shares were executed at a range of prices from $124.4915 to $125.4914. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
/s/ Seaneen Cline, by power of attorney for Jeanne Beliveau-Dunn
2024-02-16
EX-24
2
beliveaudunn_poa.txt
J BELIVEAU-DUNN POA
POWER OF ATTORNEY
The undersigned, Jeanne Beliveau-Dunn, does hereby nominate constitute and
appoint each of Kelly O'Shea, Juliene Patton, Callie Plant, Seaneen Cline and
Dorothy Capers as his/her/their true and lawful attorneys and agents to do any
and all acts and things and execute and file any and all instruments which
said attorneys and agents may deem necessary or advisable to enable the
undersigned (in his/her/their individual capacity or in any other capacity)
to comply with the Securities Exchange Act of 1934 (the "34 Act") and the
Securities Act of 1933 (the "33 Act") and any requirements of the Securities
and Exchange Commission (the "SEC") in respect thereof, in connection with
the preparation, execution and/or filing of (i) any report or statement of
beneficial ownership or changes in beneficial ownership of securities of Xylem
Inc., an Indiana corporation (the "Company"), that the undersigned
(in his/her/their individual capacity or in any other capacity) may be
required to file pursuant to Section 16(a) of the 34 Act, including any report
or statement on Form 3, Form 4 or Form 5, or to any amendment thereto, (ii)
any report or notice required under Rule 144 of the 33 Act, including
Form 144, or any amendment thereto relating to the undersigned's role with, or
beneficial ownership of, the Company's securities, and (iii) any and all other
documents or instruments that may be necessary or desirable in connection with
or in furtherance of any of the foregoing, including Form ID, or any
amendments thereto, and any other documents necessary or appropriate to obtain
codes and passwords enabling the undersigned to make electronic filings with
the SEC of reports required pursuant to Section 16(a) of the 34 Act or any
rule or regulation of the SEC,such power and authority to extend to any form
or forms adopted by the SEC in lieu of or in addition to any of the foregoing
and to include full power and authority to sign the undersigned's name in
his/her/their individual capacity or otherwise, hereby ratifying and
confirming all that said attorneys and agents or any of them, shall do or
cause to be done by virtue thereof.
This authorization shall supersede all prior authorizations to act for the
undersigned with respect to securities of the Company in such matters, which
prior authorizations are hereby revoked, and shall remain in effect until the
undersigned is no longer required to file Form 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company
unless earlier revoked, by the undersigned in a signed writing delivered to
the foregoing attorneys in fact.
IN WITNESS WHEREOF, I have hereunto set my hand this 7th day of November 2023.
_____________________________
/s/ Jeanne Beliveau-Dunn